-
Transcriptomic analysis of cell-of-origin CNS neuroblastoma, FOXR2 activated
Study
EGAS00001007247
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
early-Duodenal Cancer sequencing study
Study
EGAS00001006357
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
Bone marrow single cell genomics from blood cancer samples
Study
EGAS00001007332
-
Towards standardized whole exome sequencing (WES) for cancer patients: lessons from a multicentric pilot study
Study
EGAS00001007363
-
Analysis of the Elements Involved in the Enrichment of a Panel of Genomic Regions by Nanopore Sequencing Using Adaptive Sampling
Study
EGAS00001007375
-
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency
Study
EGAS00001007393
-
Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer
Study
EGAS00001007396
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types
Study
EGAS00001007412
-
checup
Study
EGAS00001007403
-
Epithelioid haemangioendothelioma (EHE) case series from the Stafford Fox Rare Cancer Program
Study
EGAS00001007474
-
Germline sequencing
Study
EGAS00001006651
-
Genome-wide association study of esophageal squamous cell cancer identifies shared and distinct risk variants in African and Chinese populations
Study
EGAS00001007477
-
Whole Genome Sequence and RNASeq Samples for Lung Cancer
Study
EGAS00001007832
-
Discrepancies in Tumour Mutation Burden (TMB) reporting from sequential Endobronchial ultrasound trans bronchial needle aspiration (EBUS TBNA) samples within single lymph node stations
Study
EGAS00001007484
-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Study
EGAS00001007501
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Study
EGAS00001007545
-
Immune and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 trials
Study
EGAS00001007563
-
Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers
Study
EGAS00001007574
-
DERMATLAS__Leiomyoma_WES
Study
EGAS00001007629
-
DERMATLAS__Leiomyoma_RNAseq
Study
EGAS00001007630
-
Buccal Sample Methylation for Breast Cancer Detection
Study
EGAS00001007658
-
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with Constitutional Mismatch Repair Deficiency
Study
EGAS00001007660
-
DNA-methylation variability in normal mucosa of patients with adenomatous polyps: a marker of field cancerization
Study
EGAS00001007666
-
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Study
EGAS00001007766
-
Evaluation of EBUS-TBNA Aspirates from Advanced NSCLC for Comprehensive Sequencing Platforms Including Whole Genome Sequencing
Study
EGAS00001007708
-
To_profile_the_landscape_of_sebaceous_tumours___RNA
Study
EGAS00001007803
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
The University of Hong Kong Intestinal Metaplasia Organoids Study
Study
EGAS00001007899
-
Phosphoproteomics adds value to treatment recommendations in molecular tumor boards
Study
EGAS00001007891
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Integrated genomic analysis for HCC
Study
EGAS00001007957
-
Detection of cancers three years prior to diagnosis using plasma cell-free DNA
Study
EGAS00001008068
-
This study generated Oxford Nanopore long read sequencing data of cancer cell line mixtures for validating long-read variant calls in cancer genomics
Study
EGAS00001008107
-
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Study
EGAS00001008140
-
Single cell TCRseq data fromTIL and non-TIL expanded TRACERx samples in the manuscript Bulk TCRseq from TRACERx samples from 'Subclonal immune evasion in non-small cell lung cancer'
Study
EGAS00001008161
-
Transcriptomic predictors of survival for palbociclib + endocrine therapy vs. capecitabine in aromatase inhibitor-resistant breast cancer from GEICAM/2013-02 PEARL
Study
EGAS00001008177
-
Cold Ischemia Study
Study
EGAS00001008233
-
Colorectal Microenvironment Spatial Mapping
Study
EGAS00001008254
-
Single_cell_RNA_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008271
-
Whole_Genome_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008274
-
Single_cell_ATAC_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008276
-
Cell-free DNA sequencing data of healthy control, atrophic gastritis, and gastric cancer patients’ blood
Study
EGAS00001007308
-
Single_cell_ATAC_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008279
-
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling
Study
EGAS00001008353
-
Sequencing of patient tissue and patient derived organoids in colon cancer
Study
EGAS00001008067
-
Whole-transcriptome characterization of cell-free RNA (cfRNA) in cancer and non-cancer patients
Dataset
EGAD00001006484